UTMD (Utah Medical Products Inc) Stock Analysis - Insider Trades
Utah Medical Products Inc (UTMD) is a publicly traded Healthcare sector company. As of May 21, 2026, UTMD trades at $64.17 with a market cap of $203.78M and a P/E ratio of 19.03. UTMD moved +0.00% today. Year to date, UTMD is +11.41%; over the trailing twelve months it is +18.35%. Its 52-week range spans $51.26 to $71.81. Rallies surfaces UTMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading UTMD stock inside the company?
Recent UTMD insider activity includes RICHINS PAUL O sold 700, RICHINS PAUL O sold 449, RICHINS PAUL O sold 161, RICHINS PAUL O sold 40, and PAYNE BARBARA A sold 2.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
UTMD Key Metrics
Key financial metrics for UTMD
Metric
Value
Price
$64.17
Market Cap
$203.78M
P/E Ratio
19.03
EPS
$3.38
Dividend Yield
0.31%
52-Week High
$71.81
52-Week Low
$51.26
Volume
0
Avg Volume
0
Revenue (TTM)
$37.53M
Net Income
$10.85M
Gross Margin
57.94%
Recent UTMD Insider Trades
RICHINS PAUL O sold 700 (~$65.43K) on May 18, 2023.
RICHINS PAUL O sold 449 (~$40.77K) on Nov 18, 2022.
RICHINS PAUL O sold 161 (~$14.49K) on Nov 17, 2022.
RICHINS PAUL O sold 40 (~$3.70K) on Nov 11, 2022.
PAYNE BARBARA A sold 2.00K (~$170.40K) on May 11, 2022.
UTMD analyst coverage data. Average price target: $0.00.
Common questions about UTMD
Who is trading UTMD stock inside the company?
Recent UTMD insider activity includes RICHINS PAUL O sold 700, RICHINS PAUL O sold 449, RICHINS PAUL O sold 161, RICHINS PAUL O sold 40, and PAYNE BARBARA A sold 2.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for UTMD?
Yes. Rallies tracks UTMD insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is UTMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for UTMD. It does not provide personalized investment advice.
